607 results on '"Oliva-Hemker, Maria"'
Search Results
152. Two single group, prospective, baseline-controlled feeding studies in infants and children with chronic diarrhea fed a hypoallergenic free amino acid-based formula
153. 961 Long-Term Outcome of Children With Crohn's Disease: Results From a Large Multi-Center North American Inception Cohort
154. Tu1190 Clinical Outcome and Prediction of Final Diagnosis in Pediatric Inflammatory Bowel Disease Unclassified (IBD-U) Patients
155. 90 Durability of Maintenance Infliximab Therapy in Children With Crohn's Disease: Are Gender and Concomitant Immunomodulators More Important Than We Thought?
156. 45 Decreased Diversity of the Fecal Microbiome in Pediatric Carriage of Clostridium difficile
157. 441 Endoscopic Assessment of Mucosal Activity in Pediatric Ulcerative Colitis: Are Current Methods Reliable?
158. Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease
159. Evaluation of a free amino acid–based formula in infants with presumptive food protein–induced proctocolitis
160. Clostridium difficile Carriage and Serum Antitoxin Responses in Children with Inflammatory Bowel Disease
161. TGFβ Receptor Mutations Impose a Strong Predisposition for Human Allergic Disease
162. Magnet Ingestions in Children Presenting to US Emergency Departments, 2002–2011
163. 953 Prolonged Exposure to Prednisone Is Decreasing in Children With Inflammatory Bowel Disease (IBD) During the Last Decade
164. 832 Clostridium difficile Carriage and Serum Antibody Responses in Pediatric Outpatients With Inflammatory Bowel Disease
165. Su1829 Mutations in TGFβR1 and 2 Are Associated With Food Allergy, Eosinophilic Gastrointestinal Disease, and Inflammatory Bowel Disease
166. 834 Ileal Transcriptome Analysis Reveals Mucosal Immune Maturation With Increasing Age-of-Onset in Pediatric Crohn Disease and Healthy Controls - A Mucosal Gene Expression Based Signature That Supports the Paris Classification for Age-of-Onset
167. 692 Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease
168. Su2010 The Prevalence of Clostridium difficile Infection in Hospitalized Pediatric and Adult Patients With Inflammatory Bowel Disease
169. 829 Early Anti-TNFα Therapy Is Superior to Early Immunomodulator Therapy in Newly Diagnosed Children With Crohn's Disease
170. 831 Prospective Cohort Study of Methotrexate Use in Treatment of Pediatric Crohn Disease
171. A Mendelian Presentation of Multiple TH2-Mediated Allergic Diseases
172. Outcome Following Aminosalicylate Therapy in Children Newly Diagnosed As Having Ulcerative Colitis
173. Contribution of higher risk genes and European admixture to Crohnʼs disease in African Americans
174. Prevalence of Enterotoxigenic Bacteroides fragilis Detected in Stool Samples from Pediatric Inflammatory Bowel Disease Patients
175. Budesonide Use in Pediatric Crohn Disease
176. 140 Anti-Microbial Serology Patterns in 824 Children With Newly Diagnosed Crohn's Disease: Association With GM-CSF Auto-Antibodies and Specific Clinical Phenotypes
177. 142 Prospective Multicenter Pediatric Cohort Study: Patients With Liver Enzyme Elevations in the First 3 Months After Diagnosis of Inflammatory Bowel Disease are at Increased Risk of Chronic Liver Disease
178. Sa1884 Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease
179. 139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease
180. 141 Assessment of Durability of Infliximab Maintenance Therapy in Children With Crohn's Disease
181. Sa1982 Detecting Enterotoxigenic Bacteroides Fragilis Carriage in Pediatric Inflammatory Bowel Disease
182. MR Enterography Findings of Inflammatory Bowel Disease in Pediatric Patients
183. Changing Trends in Pharmacologic Therapy of Pediatric Crohn's Disease
184. Post-Intestinal Resection Management of Pediatric Crohn's Disease
185. Outcomes Following Aminosalicylate Therapy in Children Newly Diagnosed With Ulcerative Colitis: A Prospective Multi-Center Registry Experience
186. Outcome Following Thiopurine Use in Children With Ulcerative Colitis: A Prospective Multicenter Registry Study
187. The Prometheus Crohn's Prognostic Test Does Not Reliably Predict Complicated Crohn's Disease in Children
188. Real-time tool to display the predicted disease course and treatment response for children with Crohnʼs disease
189. Recognizing Gastrointestinal and Hepatic Manifestations of Primary Immunodeficiency Diseases
190. Factors That Determine Risk for Surgery in Pediatric Patients With Crohn's Disease
191. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity
192. Outcome Following Infliximab Therapy in Children With Ulcerative Colitis
193. S2005 Clinical Effect and Changing Patterns of use of Methotrexate in the Treatment of Pediatric Crohn's Disease: A Multi-Center Experience
194. S2023 NOD2 Mutations and Presenting Clinical Characteristics of Crohn's Disease (CD) in Children
195. 506 Outcome Following Thiopurine use in Children With Ulcerative Colitis: A Prospective Multicenter Study
196. S1189 Upper Gastrointestinal Involvement in Pediatric Crohn's Disease: Experience of a Large Multicenter Inception Cohort
197. Outcome After Percutaneous Endoscopic Gastrostomy in Children and Young Adults
198. NOD2 Mutations and Anti- Saccharomyces cerevisiae Antibodies Are Risk Factors for Crohn's Disease in African Americans
199. Long Term Use of Adalimumab in Pediatric Crohnʼs Disease: A Multi-Center Study
200. Appraisal of the pediatric ulcerative colitis activity index (PUCAI)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.